People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

As researchers continue to delve into the potential of psilocybin, understanding its risks is crucial for ensuring that the ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

A new study has demonstrated the potential impact of psilocybin-assisted therapy on people with depression, if approved by ...

In 2022, voters in Colorado voted to decriminalize psychedelic mushrooms and create healing centers for psilocybin therapy.

Aspen City Council on Monday mulled over how to determine specific boundaries around cultivation, distribution and use of the ...

As psychedelic medicine inches closer to mainstream acceptance, researchers have tackled a crucial question: How many ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

MONTPELIER, Vt. (WCAX) - A new report shows Vermont may not move forward -- yet -- on psychedelic therapy.

Colorado’s rollout will be closely watched as a national model as the federal government navigates the waning years of a ...

Joe McKay tried everything medicine had to offer for the blinding headaches that began in the months after 9/11, when the ...